A HANDBOOK ON QUINTILIAN - (M.) van der Poel, (M.) Edwards, (J.J.) Murphy (edd.) The Oxford Handbook of Quintilian. Pp. xii + 570, ills. Oxford: Oxford University Press, 2021. Cased, £110, US$145. ISBN: 978-0-19-871378-4

Autor: Christopher Whitton

Publikováno v: The Classical Review. 73:145-147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8def89966f7a7732f75a04f9e6e49a5b
https://doi.org/10.1017/s0009840x2200213x

Preliminary Material

Autor: Lardinois, A., author, Blok, J., author, Poel, M. Van Der, author

Publikováno v: Sacred Words: Orality, Literacy and Religion: Orality and Literacy in the Ancient World, vol. 8. 332:i-xiv

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial.

Autor: Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France. catherine.thieblemont@aphp.fr., Karimi YH; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Cheah CY; Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia., Clausen MR; Vejle Hospital, Vejle, Denmark., Cunningham D; The Royal Marsden NHS Foundation Trust, Sutton, UK., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Do YR; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Gasiorowski R; Concord Hospital, University of Sydney, Sydney, Australia., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, UK., Kim TM; Seoul National University Hospital, Seoul, Republic of Korea., van der Poel M; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Poon ML; National University Hospital, Singapore, Singapore., Feldman T; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack Meridian Health School of Medicine, Hackensack, NJ, USA., Linton KM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Hutchings M; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Dinh MH; AbbVie, North Chicago, IL, USA., Kilavuz N; Genmab, Plainsboro, NJ, USA., Soong D; Genmab, Plainsboro, NJ, USA., Mark T; Genmab, Copenhagen, Denmark., Sacchi M; Genmab, Plainsboro, NJ, USA., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; City of Hope, Duarte, CA, USA., Lugtenburg PJ; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology, University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2653-2662. Date of Electronic Publication: 2024 Sep 25.

Build up of off-diagonal long-range order in microcavity exciton-polaritons across the parametric threshold

Autor: Spano, R., Cuadra, J., Lingg, C., Sanvitto, D., Martin, M. D., Eastham, P. R., van der Poel, M., Hvam, J. M., Vina, L.

We report an experimental study of the spontaneous spatial and temporal coherence of polariton condensates generated in the optical parametric oscillator configuration, below and at the parametric threshold, and as a function of condensate area. Abov

Externí odkaz: http://arxiv.org/abs/1111.4894

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.

Autor: Jain T; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Estrada-Merly N; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Salas MQ; Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology, Hospital Clínic de Barcelona, Barcelona, Spain., Kim S; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., DeVos J; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Chen M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Fang X; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Kumar R; Princess Margaret Cancer Centre, Toronto, Canada., Andrade-Campos M; Hospital del Mar Research Institute, Barcelona, Spain., Elmariah H; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Center and Research Institute, Tampa, FL., Agrawal V; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Aljurf M; Oncology Center, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Badar T; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Badawy SM; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Ballen K; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL., Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE., Bredeson C; The Ottawa Hospital Transplantation and Cellular Therapy Program and Ottawa Hospital Research Institute, Ottawa, ON, Canada., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Dholaria B; Vanderbilt University Medical Center, Nashville, TN., Farhadfar N; Sarah Cannon Transplant & Cellular Program at Methodist Hospital, San Antonio, TX., Farhan S; Henry Ford Health System Stem Cell Transplant & Cellular Therapy Program, Detroit, MI., Gandhi AP; Division of Hematology/Medical Oncology, Oregon Health and Science University, Portland, OR., Ganguly S; Houston Methodist Hospital and Neal Cancer Center, Houston, TX., Gergis U; Division of Hematological Malignancies, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC., Hamad N; Department of Hematology, St. Vincent's Hospital Sydney, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.; School of Medicine, University of Notre Dame, Sydney, Australia., Hamilton BK; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Inamoto Y; Department of BMT & Cellular Therapy, Fujita Health University School of Medicine, Toyoake, Japan., Iqbal M; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Jamy O; University of Alabama at Birmingham, Birmingham, AL., Juckett M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Krem MM; Kansas City VA Medical Center, Kansas City, MO., Lad DP; Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology, Department of Medicine, The University of British Columbia, Vancouver, Canada., Liesveld J; Department of Medicine, University of Rochester Medical Center, Rochester, NY., Al Malki MM; City of Hope National Medical Center, Duarte, CA., Malone AK; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Ortí G; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Patel SS; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Pawarode A; Adult Blood and Marrow Transplantation and Cellular Therapy, Rogel Cancer Center, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., van der Poel M; Division of Hematology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Ringden O; Translational Cell Therapy Group, Clinical Science, Intervention, and Technology Karolinska Institutet, Stockholm, Sweden., Rizzieri DA; Novant Health Cancer Institute, Winston Salem, NC., Rovó A; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Savoie ML; University of Calgary, Calgary, AB, Canada., Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Solh M; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA., Ustun C; Division of Hematology, Oncology, and Cell Therapy, RUSH University, Chicago, IL., Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands., Wingard JR; Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL., Wirk B; Virginia Commonwealth University, Massey Comprehensive Cancer Center, Richmond, VA., Bejanyan N; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Center and Research Institute, Tampa, FL., Jones RJ; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Department of Oncologic Sciences, Morsani College of Medicine, University South of Florida, Tampa, FL., Oran B; Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX., Nakamura R; City of Hope National Medical Center, Duarte, CA., Scott B; Fred Hutchinson Cancer Research Center, Seattle, WA., Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Gupta V; Princess Margaret Cancer Centre, Toronto, Canada.

Publikováno v: Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4281-4293.